Invasive group A Streptococcus disease in Australian children - 2016 to 2018: A descriptive cohort study

Jane Oliver, Elise Thielemans, Alissa McMinn, Ciara Baker, Philip N. Britton, Julia E. Clark, Helen S. Marshall, Christopher C. Blyth, Joshua Francis, Jim Buttery, Andrew C. Steer, Nigel W. Crawford

Research output: Contribution to journalArticlepeer-review

38 Downloads (Pure)


Objectives: Invasive group A Streptococcus (iGAS) disease is serious and sometimes life-threatening. The Paediatric Active Enhanced Disease Surveillance (PAEDS) Network collects voluntary notifications from seven major Australian paediatric hospitals on patients with certain conditions, including iGAS disease. Our aims were to: 1) Describe the epidemiological distribution of paediatric iGAS disease in Australia and correlate this with influenza notifications, 2) Identify GAS strains commonly associated with invasive disease in children. 

Methods: IGAS and influenza notification data were obtained (from the PAEDS Network and the Australian Institute of Health and Welfare, respectively, for the period 1 July 2016 to 30 June 2018). Included iGAS patients had GAS isolated from a normally sterile body site. Data were described according to selected clinical and demographic characteristics, including by age group and Australian State, with proportions and minimum incidence rates estimated. 

Results: A total of 181 patients were identified, with most (115, 63.5%) <5 years old. The mean annual minimum incidence rate was 1.6 (95% confidence interval: 1.1-2.3) per 100,000 children across the study period. An epidemiological correlation with the seasonal burden of influenza was noted. Contact prophylaxis was not consistently offered. Of 96 patients with emm-typing results available, 72.9% showed emm-1,-4 or-12. 

Conclusions: Robust surveillance systems and cohesive patient management guidelines are needed. Making iGAS disease nationally notifiable would help facilitate this. Influenza vaccination may contribute to reducing seasonal increases in iGAS incidence. The burden of disease emphasises the need for ongoing progress in GAS vaccine development.

Original languageEnglish
Article number1750
Pages (from-to)1-10
Number of pages10
JournalBMC Public Health
Issue number1
Publication statusPublished - 30 Dec 2019


Dive into the research topics of 'Invasive group A Streptococcus disease in Australian children - 2016 to 2018: A descriptive cohort study'. Together they form a unique fingerprint.

Cite this